Legal & General Group
CABA icon

Legal & General Group’s Cabaletta Bio CABA Stock Holding History

Legal & General Group’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,961
Closed -$5.49K – 3435
2025
Q1 		$5.49K Hold
3,961
– – ﹤0.01% 3262
2024
Q4 		$8.99K Hold
3,961
– – ﹤0.01% 3269
2024
Q3 		$18.7K Sell
3,961
-22,759
-85% -$132K ﹤0.01% 3078
2024
Q2 		$200K Buy
26,720
+3,302
+14% +$40.5K ﹤0.01% 2668
2024
Q1 		$400K Sell
23,418
-2,193
-9% -$47.1K ﹤0.01% 2513
2023
Q4 		$581K Sell
25,611
-6,032
-19% -$101K ﹤0.01% 2396
2023
Q3 		$482K Buy
31,643
+28,612
+944% +$391K ﹤0.01% 2457
2023
Q2 		$39.1K Buy
+3,031
New +$32.9K ﹤0.01% 2902
2021
Q2 		– Sell
-1,138
Closed -$13K – 3506
2021
Q1 		$13K Hold
1,138
– – ﹤0.01% 3296
2020
Q4 		$14K Hold
1,138
– – ﹤0.01% 3216
2020
Q3 		$12K Sell
1,138
-488
-30% -$5.61K ﹤0.01% 3146
2020
Q2 		$18K Buy
1,626
+737
+83% +$5.64K ﹤0.01% 3101
2020
Q1 		$6K Sell
889
-541
-38% -$7.42K ﹤0.01% 3237
2019
Q4 		$20K Buy
+1,430
New +$16.9K ﹤0.01% 3184

Other funds holding CABA

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $359M AUM 7.93% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

Legal & General Group's CABA Position: Q2 2025 in Review

Legal & General Group sold out of Cabaletta Bio (CABA) in Q2 2025, closing a stake of 3,961 shares — an estimated $5.49K sold.

Legal & General Group first reported a position in CABA in Q4 2019 and held it in 14 quarters. The position peaked at $581K in Q4 2023. 86 funds tracked by Wall St. Rank hold CABA as of Q2 2025.

  • Legal & General Group reported no remaining Cabaletta Bio position as of Q2 2025 after selling out during the quarter.
  • Legal & General Group sold 3,961 Cabaletta Bio shares in Q2 2025, an estimated $5.49K.
  • Legal & General Group first reported a position in Cabaletta Bio in Q4 2019 and held it in 14 quarters.
  • Legal & General Group's Cabaletta Bio position peaked at $581K in Q4 2023.
  • 86 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2025.

Based on Legal & General Group's 13F filing for Q2 2025, filed 12 Aug 2025.